Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.
Sinn, Bruno Valentin
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy. [electronic resource] - Breast cancer research : BCR 12 2019 - 142 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1465-542X
10.1186/s13058-019-1231-z doi
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Biomarkers, Tumor
Breast Neoplasms--drug therapy
Female
Gene Expression
Histocompatibility Antigens Class I--genetics
Humans
Immunohistochemistry
Lymphocytes, Tumor-Infiltrating--immunology
Neoadjuvant Therapy
Neoplasm Staging
Prognosis
Proportional Hazards Models
Receptor, ErbB-2--deficiency
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Treatment Outcome
Tumor Microenvironment
Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy. [electronic resource] - Breast cancer research : BCR 12 2019 - 142 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1465-542X
10.1186/s13058-019-1231-z doi
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Biomarkers, Tumor
Breast Neoplasms--drug therapy
Female
Gene Expression
Histocompatibility Antigens Class I--genetics
Humans
Immunohistochemistry
Lymphocytes, Tumor-Infiltrating--immunology
Neoadjuvant Therapy
Neoplasm Staging
Prognosis
Proportional Hazards Models
Receptor, ErbB-2--deficiency
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Treatment Outcome
Tumor Microenvironment